These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 17305649

  • 1. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB, Choe PG, Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW.
    J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
    Brumme ZL, Henrick BM, Brumme CJ, Hogg RS, Montaner JS, Harrigan PR.
    Antivir Ther; 2005 Mar; 10(7):849-53. PubMed ID: 16312181
    [Abstract] [Full Text] [Related]

  • 5. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G, Italian MASTER Cohort.
    Antivir Ther; 2007 Mar; 12(6):941-7. PubMed ID: 17926648
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group.
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [Abstract] [Full Text] [Related]

  • 7. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 8. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
    Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD, EuroSIDA Study Group.
    AIDS; 2008 Oct 18; 22(16):2187-98. PubMed ID: 18832882
    [Abstract] [Full Text] [Related]

  • 9. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
    Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B.
    Clin Infect Dis; 2009 Nov 01; 49(9):1433-40. PubMed ID: 19807275
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.
    J Infect Dis; 2007 Oct 01; 196(7):1044-52. PubMed ID: 17763327
    [Abstract] [Full Text] [Related]

  • 11. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
    Cain LE, Cole SR, Chmiel JS, Margolick JB, Rinaldo CR, Detels R.
    Am J Epidemiol; 2006 Feb 15; 163(4):310-5. PubMed ID: 16371516
    [Abstract] [Full Text] [Related]

  • 12. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM.
    Clin Infect Dis; 2007 Dec 15; 45(12):1633-9. PubMed ID: 18190326
    [Abstract] [Full Text] [Related]

  • 13. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients.
    Ho C, Lee S, Wong Kh, Cheng L, Lam M.
    HIV Med; 2007 Apr 15; 8(3):181-5. PubMed ID: 17461862
    [Abstract] [Full Text] [Related]

  • 14. Adherence to highly active antiretroviral therapy (HAAT) at a Federal Medical Centre.
    Shaahu VN, Lawoyin TO, Sangowawa AO.
    Afr J Med Med Sci; 2008 Mar 15; 37(1):29-36. PubMed ID: 18756852
    [Abstract] [Full Text] [Related]

  • 15. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice.
    Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garré M, Chêne G, Leport C, Carrieri MP, Le Moings V, ANRS CO-8 APROCO-COPILOTE Study Group.
    Antivir Ther; 2007 Mar 15; 12(7):1067-74. PubMed ID: 18018765
    [Abstract] [Full Text] [Related]

  • 16. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun 15; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 17. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.
    HIV Med; 2007 Mar 15; 8(2):75-9. PubMed ID: 17352762
    [Abstract] [Full Text] [Related]

  • 18. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S, Alary M, Koffi CK.
    AIDS; 2007 Aug 20; 21(13):1799-803. PubMed ID: 17690579
    [Abstract] [Full Text] [Related]

  • 19. Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
    Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.
    HIV Med; 2007 Mar 20; 8(2):80-5. PubMed ID: 17352763
    [Abstract] [Full Text] [Related]

  • 20. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS.
    AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.